Biohaven (BHVN) Accounts Payables (2021 - 2026)
Biohaven (BHVN) posted Accounts Payables of $10.4 million for Q1 2026, down 10.49% sequentially from $11.6 million in Q4 2025, and down 45.55% YoY from $19.1 million in Q1 2025.
Biohaven (BHVN) Accounts Payables (2021 - 2026) Analysis & Trends
Biohaven has reported Accounts Payables for 6 years, with the latest figure at $10.4 million in Q1 2026.
- Quarterly Accounts Payables fell 45.55% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (down 45.55% YoY) and the FY2025 annual result came in at $11.6 million, down 35.42% from the prior year.
- Accounts Payables retreated to $10.4 million in Q1 2026 per BHVN's latest filing, from $11.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $36.4 million in Q1 2024 and troughed at $4.7 million in Q3 2022.
- A 5-year average of $15.8 million and a median of $15.6 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables jumped 151.69% in 2024, then sank 47.39% in 2025.
- Over 5 years, Accounts Payables stood at $10.7 million in 2022, then jumped by 45.54% to $15.6 million in 2023, then advanced by 15.74% to $18.0 million in 2024, then plunged by 35.42% to $11.6 million in 2025, then fell by 10.49% to $10.4 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $10.4 million, $11.6 million, and $17.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | 12.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.11 Mn |
| Mar 31, 2026 | 10.42 Mn |
| Dec 31, 2025 | 11.64 Mn |
| Sep 30, 2025 | 17.49 Mn |
| Jun 30, 2025 | 19.63 Mn |
| Mar 31, 2025 | 19.14 Mn |
| Dec 31, 2024 | 18.03 Mn |
| Sep 30, 2024 | 19.74 Mn |
| Jun 30, 2024 | 17.26 Mn |
| Mar 31, 2024 | 36.39 Mn |
| Dec 31, 2023 | 15.58 Mn |
| Sep 30, 2023 | 9.52 Mn |
| Jun 30, 2023 | 12.04 Mn |
| Mar 31, 2023 | 14.46 Mn |
| Dec 31, 2022 | 10.70 Mn |
| Sep 30, 2022 | 4.73 Mn |
| Dec 31, 2021 | 4.78 Mn |